NV
Naga Venkata Padmini Devi Simhadri
About Naga Venkata Padmini Devi Simhadri
Naga Venkata Padmini Devi Simhadri has 15 years in corporate governance. Holds Director role. Currently with 1 company, including Simhadricop Private Limited and Simhadri And Associates Private Limited. Formerly with 2 companies, such as Yegna Manojavam Drugs & Chemicals Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Simhadricop Private Limited
U55101TS2023PTC175667
|
Director | 01 Aug 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Yegna Manojavam Drugs & Chemicals Limited
U24239TG2003PLC041563
|
Whole-Time Director | 01 Sep 2010 | 2003 | Active |
Simhadri And Associates Private Limited
U45200TG2017PTC115567
|
Director | 01 Mar 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naga Venkata Padmini Devi Simhadri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naga Venkata Padmini Devi Simhadri
Naga Venkata Padmini Devi Simhadri has 15 years in corporate governance. Holds Director role. Currently with 1 company, including Simhadricop Private Limited and Simhadri And Associates Private Limited. Formerly with 2 companies, such as Yegna Manojavam Drugs & Chemicals Limited. Engaged in General Business. Contributes to corporate operations.
Naga Venkata Padmini Devi Simhadri is associated with 1 company as Director.
Naga Venkata Padmini Devi Simhadri has expertise in General Business.
Naga Venkata Padmini Devi Simhadri has 15 years in corporate governance.